nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—CYP3A7—Ifosfamide—testicular cancer	0.0855	0.134	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0855	0.134	CbGbCtD
Felodipine—CYP3A5—Ifosfamide—testicular cancer	0.0641	0.101	CbGbCtD
Felodipine—CYP2C8—Ifosfamide—testicular cancer	0.0616	0.0967	CbGbCtD
Felodipine—CYP2C9—Ifosfamide—testicular cancer	0.043	0.0675	CbGbCtD
Felodipine—ABCB1—Dactinomycin—testicular cancer	0.0353	0.0555	CbGbCtD
Felodipine—CYP3A5—Etoposide—testicular cancer	0.0306	0.0481	CbGbCtD
Felodipine—CYP2C8—Etoposide—testicular cancer	0.0295	0.0462	CbGbCtD
Felodipine—CYP3A4—Ifosfamide—testicular cancer	0.025	0.0392	CbGbCtD
Felodipine—ABCB1—Vinblastine—testicular cancer	0.0221	0.0347	CbGbCtD
Felodipine—CYP2C9—Cisplatin—testicular cancer	0.0209	0.0328	CbGbCtD
Felodipine—CYP2D6—Vinblastine—testicular cancer	0.0209	0.0327	CbGbCtD
Felodipine—ABCB1—Cisplatin—testicular cancer	0.0203	0.0319	CbGbCtD
Felodipine—ABCB1—Etoposide—testicular cancer	0.0199	0.0313	CbGbCtD
Felodipine—ABCB1—Doxorubicin—testicular cancer	0.0136	0.0213	CbGbCtD
Felodipine—CYP3A4—Vinblastine—testicular cancer	0.0133	0.0208	CbGbCtD
Felodipine—ABCB1—Methotrexate—testicular cancer	0.0132	0.0207	CbGbCtD
Felodipine—CYP2D6—Doxorubicin—testicular cancer	0.0128	0.0201	CbGbCtD
Felodipine—CYP3A4—Etoposide—testicular cancer	0.0119	0.0188	CbGbCtD
Felodipine—CALM2—semen—testicular cancer	0.00943	0.0699	CbGeAlD
Felodipine—CALM1—semen—testicular cancer	0.00939	0.0696	CbGeAlD
Felodipine—CYP3A4—Doxorubicin—testicular cancer	0.00815	0.0128	CbGbCtD
Felodipine—TNNC2—female gonad—testicular cancer	0.00682	0.0505	CbGeAlD
Felodipine—CACNA1S—seminal vesicle—testicular cancer	0.00627	0.0465	CbGeAlD
Felodipine—TNNC2—testis—testicular cancer	0.00604	0.0448	CbGeAlD
Felodipine—PDE1B—gonad—testicular cancer	0.00441	0.0327	CbGeAlD
Felodipine—TNNC2—lymph node—testicular cancer	0.00438	0.0325	CbGeAlD
Felodipine—CACNA1H—seminal vesicle—testicular cancer	0.00399	0.0296	CbGeAlD
Felodipine—PDE1A—gonad—testicular cancer	0.00369	0.0274	CbGeAlD
Felodipine—PDE1B—testis—testicular cancer	0.00318	0.0235	CbGeAlD
Felodipine—TNNC1—testis—testicular cancer	0.00304	0.0226	CbGeAlD
Felodipine—PDE1A—female gonad—testicular cancer	0.003	0.0222	CbGeAlD
Felodipine—CACNA1H—gonad—testicular cancer	0.00288	0.0214	CbGeAlD
Felodipine—NR3C2—seminal vesicle—testicular cancer	0.00277	0.0205	CbGeAlD
Felodipine—PDE1A—testis—testicular cancer	0.00266	0.0197	CbGeAlD
Felodipine—CACNA2D2—testis—testicular cancer	0.00256	0.019	CbGeAlD
Felodipine—CALM3—seminal vesicle—testicular cancer	0.00255	0.0189	CbGeAlD
Felodipine—CACNA1H—female gonad—testicular cancer	0.00234	0.0174	CbGeAlD
Felodipine—PDE1B—lymph node—testicular cancer	0.0023	0.0171	CbGeAlD
Felodipine—TNNC1—lymph node—testicular cancer	0.00221	0.0164	CbGeAlD
Felodipine—CALM2—embryo—testicular cancer	0.00213	0.0158	CbGeAlD
Felodipine—CALM1—embryo—testicular cancer	0.00212	0.0157	CbGeAlD
Felodipine—CACNA1H—testis—testicular cancer	0.00208	0.0154	CbGeAlD
Felodipine—CACNA2D1—female gonad—testicular cancer	0.00208	0.0154	CbGeAlD
Felodipine—CALM2—seminal vesicle—testicular cancer	0.002	0.0148	CbGeAlD
Felodipine—CACNB2—testis—testicular cancer	0.00196	0.0145	CbGeAlD
Felodipine—PDE1A—lymph node—testicular cancer	0.00193	0.0143	CbGeAlD
Felodipine—CACNA2D2—lymph node—testicular cancer	0.00186	0.0138	CbGeAlD
Felodipine—CACNA2D1—testis—testicular cancer	0.00184	0.0137	CbGeAlD
Felodipine—CACNA1D—testis—testicular cancer	0.00171	0.0127	CbGeAlD
Felodipine—NR3C2—female gonad—testicular cancer	0.00162	0.012	CbGeAlD
Felodipine—CACNA1C—testis—testicular cancer	0.00158	0.0117	CbGeAlD
Felodipine—CACNA1H—lymph node—testicular cancer	0.00151	0.0112	CbGeAlD
Felodipine—CALM3—female gonad—testicular cancer	0.00149	0.0111	CbGeAlD
Felodipine—CALM2—gonad—testicular cancer	0.00144	0.0107	CbGeAlD
Felodipine—NR3C2—testis—testicular cancer	0.00144	0.0107	CbGeAlD
Felodipine—CALM1—gonad—testicular cancer	0.00144	0.0107	CbGeAlD
Felodipine—CACNB2—lymph node—testicular cancer	0.00142	0.0105	CbGeAlD
Felodipine—CACNA2D1—lymph node—testicular cancer	0.00134	0.0099	CbGeAlD
Felodipine—CALM3—testis—testicular cancer	0.00133	0.00983	CbGeAlD
Felodipine—CACNA1D—lymph node—testicular cancer	0.00124	0.00921	CbGeAlD
Felodipine—CALM2—female gonad—testicular cancer	0.00117	0.0087	CbGeAlD
Felodipine—CALM1—female gonad—testicular cancer	0.00117	0.00866	CbGeAlD
Felodipine—CACNA1C—lymph node—testicular cancer	0.00115	0.00851	CbGeAlD
Felodipine—NR3C2—lymph node—testicular cancer	0.00104	0.00774	CbGeAlD
Felodipine—CALM2—testis—testicular cancer	0.00104	0.00772	CbGeAlD
Felodipine—CALM1—testis—testicular cancer	0.00104	0.00768	CbGeAlD
Felodipine—CALM3—lymph node—testicular cancer	0.000961	0.00712	CbGeAlD
Felodipine—CYP3A5—female gonad—testicular cancer	0.000878	0.00651	CbGeAlD
Felodipine—CYP2C8—testis—testicular cancer	0.000863	0.0064	CbGeAlD
Felodipine—ABCB1—embryo—testicular cancer	0.000846	0.00627	CbGeAlD
Felodipine—ABCB1—seminal vesicle—testicular cancer	0.000794	0.00589	CbGeAlD
Felodipine—CALM2—lymph node—testicular cancer	0.000755	0.00559	CbGeAlD
Felodipine—CALM1—lymph node—testicular cancer	0.000751	0.00557	CbGeAlD
Felodipine—CYP2D6—female gonad—testicular cancer	0.000648	0.00481	CbGeAlD
Felodipine—CYP2D6—testis—testicular cancer	0.000575	0.00426	CbGeAlD
Felodipine—ABCB1—gonad—testicular cancer	0.000574	0.00426	CbGeAlD
Felodipine—ABCB1—female gonad—testicular cancer	0.000466	0.00346	CbGeAlD
Felodipine—Cerebrovascular accident—Epirubicin—testicular cancer	0.000431	0.00285	CcSEcCtD
Felodipine—Irritability—Methotrexate—testicular cancer	0.000431	0.00285	CcSEcCtD
Felodipine—Dizziness—Vinblastine—testicular cancer	0.00043	0.00284	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000428	0.00282	CcSEcCtD
Felodipine—Pain in extremity—Epirubicin—testicular cancer	0.000423	0.00279	CcSEcCtD
Felodipine—Myalgia—Cisplatin—testicular cancer	0.000422	0.00279	CcSEcCtD
Felodipine—Feeling abnormal—Dactinomycin—testicular cancer	0.000422	0.00279	CcSEcCtD
Felodipine—Nausea—Chlorambucil—testicular cancer	0.000421	0.00278	CcSEcCtD
Felodipine—Paraesthesia—Ifosfamide—testicular cancer	0.000421	0.00278	CcSEcCtD
Felodipine—Anaemia—Etoposide—testicular cancer	0.00042	0.00277	CcSEcCtD
Felodipine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000419	0.00277	CcSEcCtD
Felodipine—Dyspnoea—Ifosfamide—testicular cancer	0.000418	0.00276	CcSEcCtD
Felodipine—Somnolence—Ifosfamide—testicular cancer	0.000417	0.00276	CcSEcCtD
Felodipine—ABCB1—testis—testicular cancer	0.000414	0.00307	CbGeAlD
Felodipine—Vomiting—Vinblastine—testicular cancer	0.000413	0.00273	CcSEcCtD
Felodipine—Face oedema—Epirubicin—testicular cancer	0.000408	0.0027	CcSEcCtD
Felodipine—Vertigo—Etoposide—testicular cancer	0.000408	0.00269	CcSEcCtD
Felodipine—Headache—Vinblastine—testicular cancer	0.000407	0.00269	CcSEcCtD
Felodipine—Body temperature increased—Dactinomycin—testicular cancer	0.000405	0.00267	CcSEcCtD
Felodipine—Abdominal pain—Dactinomycin—testicular cancer	0.000405	0.00267	CcSEcCtD
Felodipine—Fatigue—Ifosfamide—testicular cancer	0.000405	0.00267	CcSEcCtD
Felodipine—Hypersensitivity—Bleomycin—testicular cancer	0.000405	0.00267	CcSEcCtD
Felodipine—Constipation—Ifosfamide—testicular cancer	0.000401	0.00265	CcSEcCtD
Felodipine—Loss of consciousness—Etoposide—testicular cancer	0.000399	0.00264	CcSEcCtD
Felodipine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000399	0.00264	CcSEcCtD
Felodipine—Cough—Etoposide—testicular cancer	0.000396	0.00262	CcSEcCtD
Felodipine—Tachycardia—Cisplatin—testicular cancer	0.000395	0.00261	CcSEcCtD
Felodipine—Asthenia—Bleomycin—testicular cancer	0.000394	0.0026	CcSEcCtD
Felodipine—Pain in extremity—Doxorubicin—testicular cancer	0.000391	0.00258	CcSEcCtD
Felodipine—Pruritus—Bleomycin—testicular cancer	0.000389	0.00257	CcSEcCtD
Felodipine—Feeling abnormal—Ifosfamide—testicular cancer	0.000387	0.00255	CcSEcCtD
Felodipine—Chest pain—Etoposide—testicular cancer	0.000387	0.00255	CcSEcCtD
Felodipine—Nausea—Vinblastine—testicular cancer	0.000386	0.00255	CcSEcCtD
Felodipine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000386	0.00255	CcSEcCtD
Felodipine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000384	0.00253	CcSEcCtD
Felodipine—Nasopharyngitis—Epirubicin—testicular cancer	0.000378	0.0025	CcSEcCtD
Felodipine—Face oedema—Doxorubicin—testicular cancer	0.000378	0.00249	CcSEcCtD
Felodipine—Hypersensitivity—Dactinomycin—testicular cancer	0.000377	0.00249	CcSEcCtD
Felodipine—Abdominal discomfort—Methotrexate—testicular cancer	0.000374	0.00247	CcSEcCtD
Felodipine—Confusional state—Etoposide—testicular cancer	0.000374	0.00247	CcSEcCtD
Felodipine—Urticaria—Ifosfamide—testicular cancer	0.000373	0.00246	CcSEcCtD
Felodipine—Abdominal pain—Ifosfamide—testicular cancer	0.000371	0.00245	CcSEcCtD
Felodipine—Body temperature increased—Ifosfamide—testicular cancer	0.000371	0.00245	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000369	0.00243	CcSEcCtD
Felodipine—Asthenia—Dactinomycin—testicular cancer	0.000367	0.00243	CcSEcCtD
Felodipine—Influenza—Epirubicin—testicular cancer	0.000365	0.00241	CcSEcCtD
Felodipine—Dysuria—Methotrexate—testicular cancer	0.000365	0.00241	CcSEcCtD
Felodipine—Paraesthesia—Cisplatin—testicular cancer	0.000363	0.0024	CcSEcCtD
Felodipine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000363	0.0024	CcSEcCtD
Felodipine—Tachycardia—Etoposide—testicular cancer	0.000362	0.00239	CcSEcCtD
Felodipine—Dyspnoea—Cisplatin—testicular cancer	0.000361	0.00238	CcSEcCtD
Felodipine—Erectile dysfunction—Methotrexate—testicular cancer	0.00036	0.00237	CcSEcCtD
Felodipine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000357	0.00236	CcSEcCtD
Felodipine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000356	0.00235	CcSEcCtD
Felodipine—Angina pectoris—Epirubicin—testicular cancer	0.000356	0.00235	CcSEcCtD
Felodipine—Bronchitis—Epirubicin—testicular cancer	0.000351	0.00232	CcSEcCtD
Felodipine—Diarrhoea—Dactinomycin—testicular cancer	0.00035	0.00231	CcSEcCtD
Felodipine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00035	0.00231	CcSEcCtD
Felodipine—Vomiting—Bleomycin—testicular cancer	0.000349	0.00231	CcSEcCtD
Felodipine—Rash—Bleomycin—testicular cancer	0.000346	0.00229	CcSEcCtD
Felodipine—Dermatitis—Bleomycin—testicular cancer	0.000346	0.00228	CcSEcCtD
Felodipine—Hypersensitivity—Ifosfamide—testicular cancer	0.000346	0.00228	CcSEcCtD
Felodipine—Dysuria—Epirubicin—testicular cancer	0.000342	0.00226	CcSEcCtD
Felodipine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00034	0.00224	CcSEcCtD
Felodipine—Influenza—Doxorubicin—testicular cancer	0.000338	0.00223	CcSEcCtD
Felodipine—Pollakiuria—Epirubicin—testicular cancer	0.000338	0.00223	CcSEcCtD
Felodipine—Asthenia—Ifosfamide—testicular cancer	0.000337	0.00222	CcSEcCtD
Felodipine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000334	0.0022	CcSEcCtD
Felodipine—Feeling abnormal—Cisplatin—testicular cancer	0.000333	0.0022	CcSEcCtD
Felodipine—Paraesthesia—Etoposide—testicular cancer	0.000333	0.0022	CcSEcCtD
Felodipine—Pruritus—Ifosfamide—testicular cancer	0.000332	0.00219	CcSEcCtD
Felodipine—Dyspnoea—Etoposide—testicular cancer	0.00033	0.00218	CcSEcCtD
Felodipine—Somnolence—Etoposide—testicular cancer	0.00033	0.00218	CcSEcCtD
Felodipine—Angina pectoris—Doxorubicin—testicular cancer	0.000329	0.00217	CcSEcCtD
Felodipine—Epistaxis—Methotrexate—testicular cancer	0.000328	0.00217	CcSEcCtD
Felodipine—Nausea—Bleomycin—testicular cancer	0.000326	0.00215	CcSEcCtD
Felodipine—Vomiting—Dactinomycin—testicular cancer	0.000326	0.00215	CcSEcCtD
Felodipine—Bronchitis—Doxorubicin—testicular cancer	0.000325	0.00215	CcSEcCtD
Felodipine—Rash—Dactinomycin—testicular cancer	0.000323	0.00213	CcSEcCtD
Felodipine—Diarrhoea—Ifosfamide—testicular cancer	0.000321	0.00212	CcSEcCtD
Felodipine—Body temperature increased—Cisplatin—testicular cancer	0.00032	0.00211	CcSEcCtD
Felodipine—Fatigue—Etoposide—testicular cancer	0.00032	0.00211	CcSEcCtD
Felodipine—Constipation—Etoposide—testicular cancer	0.000317	0.00209	CcSEcCtD
Felodipine—Dysuria—Doxorubicin—testicular cancer	0.000316	0.00209	CcSEcCtD
Felodipine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000314	0.00207	CcSEcCtD
Felodipine—Pollakiuria—Doxorubicin—testicular cancer	0.000312	0.00206	CcSEcCtD
Felodipine—Dizziness—Ifosfamide—testicular cancer	0.00031	0.00205	CcSEcCtD
Felodipine—Pharyngitis—Methotrexate—testicular cancer	0.00031	0.00205	CcSEcCtD
Felodipine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000309	0.00204	CcSEcCtD
Felodipine—Epistaxis—Epirubicin—testicular cancer	0.000307	0.00203	CcSEcCtD
Felodipine—Sinusitis—Epirubicin—testicular cancer	0.000306	0.00202	CcSEcCtD
Felodipine—Feeling abnormal—Etoposide—testicular cancer	0.000305	0.00202	CcSEcCtD
Felodipine—Nausea—Dactinomycin—testicular cancer	0.000304	0.00201	CcSEcCtD
Felodipine—Gastrointestinal pain—Etoposide—testicular cancer	0.000303	0.002	CcSEcCtD
Felodipine—Visual impairment—Methotrexate—testicular cancer	0.000301	0.00199	CcSEcCtD
Felodipine—ABCB1—lymph node—testicular cancer	0.0003	0.00222	CbGeAlD
Felodipine—Vomiting—Ifosfamide—testicular cancer	0.000298	0.00197	CcSEcCtD
Felodipine—Hypersensitivity—Cisplatin—testicular cancer	0.000298	0.00197	CcSEcCtD
Felodipine—Bradycardia—Epirubicin—testicular cancer	0.000298	0.00197	CcSEcCtD
Felodipine—Rash—Ifosfamide—testicular cancer	0.000296	0.00195	CcSEcCtD
Felodipine—Dermatitis—Ifosfamide—testicular cancer	0.000296	0.00195	CcSEcCtD
Felodipine—Erythema multiforme—Methotrexate—testicular cancer	0.000296	0.00195	CcSEcCtD
Felodipine—Urticaria—Etoposide—testicular cancer	0.000294	0.00194	CcSEcCtD
Felodipine—Abdominal pain—Etoposide—testicular cancer	0.000293	0.00193	CcSEcCtD
Felodipine—Body temperature increased—Etoposide—testicular cancer	0.000293	0.00193	CcSEcCtD
Felodipine—Asthenia—Cisplatin—testicular cancer	0.00029	0.00192	CcSEcCtD
Felodipine—Pharyngitis—Epirubicin—testicular cancer	0.00029	0.00192	CcSEcCtD
Felodipine—Oedema peripheral—Epirubicin—testicular cancer	0.000288	0.0019	CcSEcCtD
Felodipine—Epistaxis—Doxorubicin—testicular cancer	0.000284	0.00188	CcSEcCtD
Felodipine—Sinusitis—Doxorubicin—testicular cancer	0.000283	0.00187	CcSEcCtD
Felodipine—Visual impairment—Epirubicin—testicular cancer	0.000282	0.00186	CcSEcCtD
Felodipine—Nausea—Ifosfamide—testicular cancer	0.000279	0.00184	CcSEcCtD
Felodipine—Diarrhoea—Cisplatin—testicular cancer	0.000277	0.00183	CcSEcCtD
Felodipine—Erythema multiforme—Epirubicin—testicular cancer	0.000277	0.00183	CcSEcCtD
Felodipine—Bradycardia—Doxorubicin—testicular cancer	0.000276	0.00182	CcSEcCtD
Felodipine—Hypersensitivity—Etoposide—testicular cancer	0.000273	0.0018	CcSEcCtD
Felodipine—Erythema—Methotrexate—testicular cancer	0.000272	0.0018	CcSEcCtD
Felodipine—Flushing—Epirubicin—testicular cancer	0.000271	0.00179	CcSEcCtD
Felodipine—Pharyngitis—Doxorubicin—testicular cancer	0.000269	0.00177	CcSEcCtD
Felodipine—Oedema peripheral—Doxorubicin—testicular cancer	0.000267	0.00176	CcSEcCtD
Felodipine—Asthenia—Etoposide—testicular cancer	0.000266	0.00176	CcSEcCtD
Felodipine—Back pain—Methotrexate—testicular cancer	0.000263	0.00174	CcSEcCtD
Felodipine—Pruritus—Etoposide—testicular cancer	0.000262	0.00173	CcSEcCtD
Felodipine—Arrhythmia—Epirubicin—testicular cancer	0.000261	0.00173	CcSEcCtD
Felodipine—Visual impairment—Doxorubicin—testicular cancer	0.000261	0.00172	CcSEcCtD
Felodipine—Vomiting—Cisplatin—testicular cancer	0.000257	0.0017	CcSEcCtD
Felodipine—Erythema multiforme—Doxorubicin—testicular cancer	0.000256	0.00169	CcSEcCtD
Felodipine—Rash—Cisplatin—testicular cancer	0.000255	0.00168	CcSEcCtD
Felodipine—Dermatitis—Cisplatin—testicular cancer	0.000255	0.00168	CcSEcCtD
Felodipine—Erythema—Epirubicin—testicular cancer	0.000255	0.00168	CcSEcCtD
Felodipine—Diarrhoea—Etoposide—testicular cancer	0.000254	0.00167	CcSEcCtD
Felodipine—Anaemia—Methotrexate—testicular cancer	0.000251	0.00166	CcSEcCtD
Felodipine—Flushing—Doxorubicin—testicular cancer	0.000251	0.00166	CcSEcCtD
Felodipine—Flatulence—Epirubicin—testicular cancer	0.000251	0.00166	CcSEcCtD
Felodipine—Tension—Epirubicin—testicular cancer	0.00025	0.00165	CcSEcCtD
Felodipine—Nervousness—Epirubicin—testicular cancer	0.000247	0.00163	CcSEcCtD
Felodipine—Back pain—Epirubicin—testicular cancer	0.000246	0.00163	CcSEcCtD
Felodipine—Dizziness—Etoposide—testicular cancer	0.000245	0.00162	CcSEcCtD
Felodipine—Muscle spasms—Epirubicin—testicular cancer	0.000245	0.00162	CcSEcCtD
Felodipine—Vertigo—Methotrexate—testicular cancer	0.000244	0.00161	CcSEcCtD
Felodipine—Arrhythmia—Doxorubicin—testicular cancer	0.000242	0.0016	CcSEcCtD
Felodipine—Nausea—Cisplatin—testicular cancer	0.00024	0.00159	CcSEcCtD
Felodipine—Cough—Methotrexate—testicular cancer	0.000237	0.00157	CcSEcCtD
Felodipine—Vomiting—Etoposide—testicular cancer	0.000236	0.00156	CcSEcCtD
Felodipine—Erythema—Doxorubicin—testicular cancer	0.000236	0.00156	CcSEcCtD
Felodipine—Anaemia—Epirubicin—testicular cancer	0.000235	0.00155	CcSEcCtD
Felodipine—Rash—Etoposide—testicular cancer	0.000234	0.00154	CcSEcCtD
Felodipine—Dermatitis—Etoposide—testicular cancer	0.000234	0.00154	CcSEcCtD
Felodipine—Headache—Etoposide—testicular cancer	0.000232	0.00153	CcSEcCtD
Felodipine—Flatulence—Doxorubicin—testicular cancer	0.000232	0.00153	CcSEcCtD
Felodipine—Myalgia—Methotrexate—testicular cancer	0.000232	0.00153	CcSEcCtD
Felodipine—Arthralgia—Methotrexate—testicular cancer	0.000232	0.00153	CcSEcCtD
Felodipine—Chest pain—Methotrexate—testicular cancer	0.000232	0.00153	CcSEcCtD
Felodipine—Tension—Doxorubicin—testicular cancer	0.000231	0.00153	CcSEcCtD
Felodipine—Nervousness—Doxorubicin—testicular cancer	0.000229	0.00151	CcSEcCtD
Felodipine—Vertigo—Epirubicin—testicular cancer	0.000229	0.00151	CcSEcCtD
Felodipine—Syncope—Epirubicin—testicular cancer	0.000228	0.00151	CcSEcCtD
Felodipine—Back pain—Doxorubicin—testicular cancer	0.000228	0.0015	CcSEcCtD
Felodipine—Muscle spasms—Doxorubicin—testicular cancer	0.000227	0.0015	CcSEcCtD
Felodipine—Palpitations—Epirubicin—testicular cancer	0.000225	0.00149	CcSEcCtD
Felodipine—Confusional state—Methotrexate—testicular cancer	0.000224	0.00148	CcSEcCtD
Felodipine—Loss of consciousness—Epirubicin—testicular cancer	0.000224	0.00148	CcSEcCtD
Felodipine—Cough—Epirubicin—testicular cancer	0.000222	0.00147	CcSEcCtD
Felodipine—Nausea—Etoposide—testicular cancer	0.00022	0.00145	CcSEcCtD
Felodipine—Anaemia—Doxorubicin—testicular cancer	0.000218	0.00144	CcSEcCtD
Felodipine—Myalgia—Epirubicin—testicular cancer	0.000217	0.00143	CcSEcCtD
Felodipine—Chest pain—Epirubicin—testicular cancer	0.000217	0.00143	CcSEcCtD
Felodipine—Arthralgia—Epirubicin—testicular cancer	0.000217	0.00143	CcSEcCtD
Felodipine—Dry mouth—Epirubicin—testicular cancer	0.000212	0.0014	CcSEcCtD
Felodipine—Vertigo—Doxorubicin—testicular cancer	0.000212	0.0014	CcSEcCtD
Felodipine—Syncope—Doxorubicin—testicular cancer	0.000211	0.00139	CcSEcCtD
Felodipine—Confusional state—Epirubicin—testicular cancer	0.00021	0.00138	CcSEcCtD
Felodipine—Palpitations—Doxorubicin—testicular cancer	0.000208	0.00137	CcSEcCtD
Felodipine—Loss of consciousness—Doxorubicin—testicular cancer	0.000207	0.00137	CcSEcCtD
Felodipine—Cough—Doxorubicin—testicular cancer	0.000206	0.00136	CcSEcCtD
Felodipine—Shock—Epirubicin—testicular cancer	0.000204	0.00135	CcSEcCtD
Felodipine—Tachycardia—Epirubicin—testicular cancer	0.000203	0.00134	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000202	0.00134	CcSEcCtD
Felodipine—Insomnia—Methotrexate—testicular cancer	0.000201	0.00133	CcSEcCtD
Felodipine—Chest pain—Doxorubicin—testicular cancer	0.000201	0.00132	CcSEcCtD
Felodipine—Myalgia—Doxorubicin—testicular cancer	0.000201	0.00132	CcSEcCtD
Felodipine—Arthralgia—Doxorubicin—testicular cancer	0.000201	0.00132	CcSEcCtD
Felodipine—Paraesthesia—Methotrexate—testicular cancer	0.000199	0.00132	CcSEcCtD
Felodipine—Dyspnoea—Methotrexate—testicular cancer	0.000198	0.00131	CcSEcCtD
Felodipine—Somnolence—Methotrexate—testicular cancer	0.000197	0.0013	CcSEcCtD
Felodipine—Dry mouth—Doxorubicin—testicular cancer	0.000196	0.0013	CcSEcCtD
Felodipine—Dyspepsia—Methotrexate—testicular cancer	0.000195	0.00129	CcSEcCtD
Felodipine—Confusional state—Doxorubicin—testicular cancer	0.000194	0.00128	CcSEcCtD
Felodipine—Fatigue—Methotrexate—testicular cancer	0.000191	0.00126	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000189	0.00125	CcSEcCtD
Felodipine—Shock—Doxorubicin—testicular cancer	0.000189	0.00125	CcSEcCtD
Felodipine—Insomnia—Epirubicin—testicular cancer	0.000188	0.00124	CcSEcCtD
Felodipine—Tachycardia—Doxorubicin—testicular cancer	0.000188	0.00124	CcSEcCtD
Felodipine—Paraesthesia—Epirubicin—testicular cancer	0.000187	0.00123	CcSEcCtD
Felodipine—Dyspnoea—Epirubicin—testicular cancer	0.000185	0.00122	CcSEcCtD
Felodipine—Somnolence—Epirubicin—testicular cancer	0.000185	0.00122	CcSEcCtD
Felodipine—Feeling abnormal—Methotrexate—testicular cancer	0.000183	0.00121	CcSEcCtD
Felodipine—Dyspepsia—Epirubicin—testicular cancer	0.000183	0.00121	CcSEcCtD
Felodipine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000182	0.0012	CcSEcCtD
Felodipine—Fatigue—Epirubicin—testicular cancer	0.000179	0.00118	CcSEcCtD
Felodipine—Constipation—Epirubicin—testicular cancer	0.000178	0.00117	CcSEcCtD
Felodipine—Urticaria—Methotrexate—testicular cancer	0.000176	0.00116	CcSEcCtD
Felodipine—Abdominal pain—Methotrexate—testicular cancer	0.000176	0.00116	CcSEcCtD
Felodipine—Body temperature increased—Methotrexate—testicular cancer	0.000176	0.00116	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000175	0.00116	CcSEcCtD
Felodipine—Insomnia—Doxorubicin—testicular cancer	0.000174	0.00115	CcSEcCtD
Felodipine—Paraesthesia—Doxorubicin—testicular cancer	0.000173	0.00114	CcSEcCtD
Felodipine—Dyspnoea—Doxorubicin—testicular cancer	0.000171	0.00113	CcSEcCtD
Felodipine—Feeling abnormal—Epirubicin—testicular cancer	0.000171	0.00113	CcSEcCtD
Felodipine—Somnolence—Doxorubicin—testicular cancer	0.000171	0.00113	CcSEcCtD
Felodipine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00017	0.00112	CcSEcCtD
Felodipine—Dyspepsia—Doxorubicin—testicular cancer	0.000169	0.00112	CcSEcCtD
Felodipine—Fatigue—Doxorubicin—testicular cancer	0.000166	0.00109	CcSEcCtD
Felodipine—Urticaria—Epirubicin—testicular cancer	0.000165	0.00109	CcSEcCtD
Felodipine—Constipation—Doxorubicin—testicular cancer	0.000164	0.00109	CcSEcCtD
Felodipine—Body temperature increased—Epirubicin—testicular cancer	0.000164	0.00108	CcSEcCtD
Felodipine—Abdominal pain—Epirubicin—testicular cancer	0.000164	0.00108	CcSEcCtD
Felodipine—Hypersensitivity—Methotrexate—testicular cancer	0.000164	0.00108	CcSEcCtD
Felodipine—Asthenia—Methotrexate—testicular cancer	0.000159	0.00105	CcSEcCtD
Felodipine—Feeling abnormal—Doxorubicin—testicular cancer	0.000158	0.00105	CcSEcCtD
Felodipine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000157	0.00104	CcSEcCtD
Felodipine—Pruritus—Methotrexate—testicular cancer	0.000157	0.00104	CcSEcCtD
Felodipine—Hypersensitivity—Epirubicin—testicular cancer	0.000153	0.00101	CcSEcCtD
Felodipine—Urticaria—Doxorubicin—testicular cancer	0.000153	0.00101	CcSEcCtD
Felodipine—Body temperature increased—Doxorubicin—testicular cancer	0.000152	0.001	CcSEcCtD
Felodipine—Abdominal pain—Doxorubicin—testicular cancer	0.000152	0.001	CcSEcCtD
Felodipine—Diarrhoea—Methotrexate—testicular cancer	0.000152	0.001	CcSEcCtD
Felodipine—CALM3—Signaling by PDGF—KITLG—testicular cancer	0.00015	0.00197	CbGpPWpGaD
Felodipine—Asthenia—Epirubicin—testicular cancer	0.000149	0.000984	CcSEcCtD
Felodipine—CALM1—DAP12 interactions—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CALM2—DAP12 interactions—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	0.000149	0.00195	CbGpPWpGaD
Felodipine—CACNA1D—Axon guidance—MMP2—testicular cancer	0.000148	0.00194	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR—KITLG—testicular cancer	0.000147	0.00193	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR—KITLG—testicular cancer	0.000147	0.00193	CbGpPWpGaD
Felodipine—Pruritus—Epirubicin—testicular cancer	0.000147	0.000971	CcSEcCtD
Felodipine—Dizziness—Methotrexate—testicular cancer	0.000147	0.00097	CcSEcCtD
Felodipine—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000146	0.00191	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000146	0.00191	CbGpPWpGaD
Felodipine—PDE1B—Immune System—BCL10—testicular cancer	0.000145	0.0019	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—KITLG—testicular cancer	0.000145	0.0019	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—KITLG—testicular cancer	0.000145	0.0019	CbGpPWpGaD
Felodipine—CALM3—B Cell Activation—KITLG—testicular cancer	0.000142	0.00186	CbGpPWpGaD
Felodipine—Diarrhoea—Epirubicin—testicular cancer	0.000142	0.000939	CcSEcCtD
Felodipine—Hypersensitivity—Doxorubicin—testicular cancer	0.000142	0.000935	CcSEcCtD
Felodipine—Vomiting—Methotrexate—testicular cancer	0.000141	0.000932	CcSEcCtD
Felodipine—Rash—Methotrexate—testicular cancer	0.00014	0.000924	CcSEcCtD
Felodipine—Dermatitis—Methotrexate—testicular cancer	0.00014	0.000924	CcSEcCtD
Felodipine—Headache—Methotrexate—testicular cancer	0.000139	0.000918	CcSEcCtD
Felodipine—Asthenia—Doxorubicin—testicular cancer	0.000138	0.000911	CcSEcCtD
Felodipine—CALM2—B Cell Activation—KITLG—testicular cancer	0.000138	0.0018	CbGpPWpGaD
Felodipine—CALM1—B Cell Activation—KITLG—testicular cancer	0.000138	0.0018	CbGpPWpGaD
Felodipine—Dizziness—Epirubicin—testicular cancer	0.000137	0.000907	CcSEcCtD
Felodipine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000137	0.00179	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000136	0.00178	CbGpPWpGaD
Felodipine—Pruritus—Doxorubicin—testicular cancer	0.000136	0.000898	CcSEcCtD
Felodipine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000132	0.00173	CbGpPWpGaD
Felodipine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000132	0.00173	CbGpPWpGaD
Felodipine—Vomiting—Epirubicin—testicular cancer	0.000132	0.000872	CcSEcCtD
Felodipine—Nausea—Methotrexate—testicular cancer	0.000132	0.000871	CcSEcCtD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000132	0.00172	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000132	0.00172	CbGpPWpGaD
Felodipine—Diarrhoea—Doxorubicin—testicular cancer	0.000132	0.000869	CcSEcCtD
Felodipine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000131	0.00172	CbGpPWpGaD
Felodipine—Rash—Epirubicin—testicular cancer	0.000131	0.000865	CcSEcCtD
Felodipine—Dermatitis—Epirubicin—testicular cancer	0.000131	0.000864	CcSEcCtD
Felodipine—Headache—Epirubicin—testicular cancer	0.00013	0.00086	CcSEcCtD
Felodipine—CACNA1S—Developmental Biology—MMP2—testicular cancer	0.00013	0.0017	CbGpPWpGaD
Felodipine—CACNA1C—Axon guidance—MMP2—testicular cancer	0.00013	0.0017	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—INSL3—testicular cancer	0.000129	0.00169	CbGpPWpGaD
Felodipine—Dizziness—Doxorubicin—testicular cancer	0.000127	0.00084	CcSEcCtD
Felodipine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000127	0.00166	CbGpPWpGaD
Felodipine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000127	0.00166	CbGpPWpGaD
Felodipine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000127	0.00166	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—INSL3—testicular cancer	0.000125	0.00164	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—INSL3—testicular cancer	0.000125	0.00164	CbGpPWpGaD
Felodipine—Nausea—Epirubicin—testicular cancer	0.000123	0.000815	CcSEcCtD
Felodipine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	0.000123	0.00161	CbGpPWpGaD
Felodipine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000123	0.00161	CbGpPWpGaD
Felodipine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000123	0.00161	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	0.000123	0.0016	CbGpPWpGaD
Felodipine—PDE1A—Innate Immune System—FGFR3—testicular cancer	0.000122	0.0016	CbGpPWpGaD
Felodipine—Vomiting—Doxorubicin—testicular cancer	0.000122	0.000807	CcSEcCtD
Felodipine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	0.000122	0.0016	CbGpPWpGaD
Felodipine—CALM3—DAP12 signaling—FGFR3—testicular cancer	0.000121	0.00159	CbGpPWpGaD
Felodipine—Rash—Doxorubicin—testicular cancer	0.000121	0.0008	CcSEcCtD
Felodipine—Dermatitis—Doxorubicin—testicular cancer	0.000121	0.0008	CcSEcCtD
Felodipine—Headache—Doxorubicin—testicular cancer	0.00012	0.000795	CcSEcCtD
Felodipine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	0.00012	0.00157	CbGpPWpGaD
Felodipine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	0.000119	0.00156	CbGpPWpGaD
Felodipine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	0.000119	0.00156	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	0.000119	0.00155	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	0.000119	0.00155	CbGpPWpGaD
Felodipine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000118	0.00155	CbGpPWpGaD
Felodipine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	0.000118	0.00154	CbGpPWpGaD
Felodipine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	0.000118	0.00154	CbGpPWpGaD
Felodipine—CALM1—DAP12 signaling—FGFR3—testicular cancer	0.000117	0.00154	CbGpPWpGaD
Felodipine—CALM2—DAP12 signaling—FGFR3—testicular cancer	0.000117	0.00154	CbGpPWpGaD
Felodipine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000116	0.00152	CbGpPWpGaD
Felodipine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000116	0.00152	CbGpPWpGaD
Felodipine—CACNA2D2—Metabolism—STK11—testicular cancer	0.000116	0.00151	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000114	0.00149	CbGpPWpGaD
Felodipine—CALM3—DAP12 interactions—FGFR3—testicular cancer	0.000114	0.00149	CbGpPWpGaD
Felodipine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000114	0.00149	CbGpPWpGaD
Felodipine—Nausea—Doxorubicin—testicular cancer	0.000114	0.000754	CcSEcCtD
Felodipine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	0.000113	0.00148	CbGpPWpGaD
Felodipine—CALM3—Downstream signal transduction—KIT—testicular cancer	0.000113	0.00148	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR—KIT—testicular cancer	0.000113	0.00147	CbGpPWpGaD
Felodipine—PDE1A—Innate Immune System—KIT—testicular cancer	0.000112	0.00147	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000112	0.00147	CbGpPWpGaD
Felodipine—CALM3—Signaling by ERBB2—KIT—testicular cancer	0.000112	0.00147	CbGpPWpGaD
Felodipine—PDE1B—Innate Immune System—FGFR3—testicular cancer	0.000112	0.00146	CbGpPWpGaD
Felodipine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	0.000112	0.00146	CbGpPWpGaD
Felodipine—CACNB2—Developmental Biology—MMP2—testicular cancer	0.000111	0.00146	CbGpPWpGaD
Felodipine—CALM3—DAP12 signaling—KIT—testicular cancer	0.000111	0.00146	CbGpPWpGaD
Felodipine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM1—DAP12 interactions—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM2—DAP12 interactions—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00011	0.00145	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CALM1—Downstream signal transduction—KIT—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CALM2—Downstream signal transduction—KIT—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CACNB2—Metabolism—HPGDS—testicular cancer	0.000109	0.00143	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR—KIT—testicular cancer	0.000109	0.00142	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR—KIT—testicular cancer	0.000109	0.00142	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000109	0.00142	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000109	0.00142	CbGpPWpGaD
Felodipine—CALM2—Signaling by ERBB2—KIT—testicular cancer	0.000108	0.00142	CbGpPWpGaD
Felodipine—CALM1—Signaling by ERBB2—KIT—testicular cancer	0.000108	0.00142	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	0.000108	0.00141	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	0.000108	0.00141	CbGpPWpGaD
Felodipine—CALM2—DAP12 signaling—KIT—testicular cancer	0.000108	0.00141	CbGpPWpGaD
Felodipine—CALM1—DAP12 signaling—KIT—testicular cancer	0.000108	0.00141	CbGpPWpGaD
Felodipine—CALM3—B Cell Activation—FGFR3—testicular cancer	0.000106	0.00138	CbGpPWpGaD
Felodipine—CACNA1D—Developmental Biology—MMP2—testicular cancer	0.000106	0.00138	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	0.000105	0.00137	CbGpPWpGaD
Felodipine—CALM3—DAP12 interactions—KIT—testicular cancer	0.000105	0.00137	CbGpPWpGaD
Felodipine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000105	0.00137	CbGpPWpGaD
Felodipine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	0.000105	0.00137	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—KITLG—testicular cancer	0.000105	0.00137	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR—KIT—testicular cancer	0.000104	0.00136	CbGpPWpGaD
Felodipine—CACNA1D—Metabolism—HPGDS—testicular cancer	0.000103	0.00135	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000103	0.00135	CbGpPWpGaD
Felodipine—PDE1B—Innate Immune System—KIT—testicular cancer	0.000103	0.00134	CbGpPWpGaD
Felodipine—CALM3—Signaling by PDGF—KIT—testicular cancer	0.000103	0.00134	CbGpPWpGaD
Felodipine—CALM2—B Cell Activation—FGFR3—testicular cancer	0.000102	0.00134	CbGpPWpGaD
Felodipine—CALM1—B Cell Activation—FGFR3—testicular cancer	0.000102	0.00134	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM2—DAP12 interactions—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM1—DAP12 interactions—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—KITLG—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—KITLG—testicular cancer	0.000101	0.00133	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000101	0.00132	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR—KIT—testicular cancer	0.000101	0.00132	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR—KIT—testicular cancer	0.000101	0.00132	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	9.96e-05	0.0013	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	9.96e-05	0.0013	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—KIT—testicular cancer	9.92e-05	0.0013	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—KIT—testicular cancer	9.92e-05	0.0013	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—BCL10—testicular cancer	9.9e-05	0.0013	CbGpPWpGaD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.79e-05	0.00128	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.79e-05	0.00128	CbGpPWpGaD
Felodipine—CALM3—B Cell Activation—KIT—testicular cancer	9.7e-05	0.00127	CbGpPWpGaD
Felodipine—PDE1A—Disease—H2AFZ—testicular cancer	9.63e-05	0.00126	CbGpPWpGaD
Felodipine—PDE1A—Immune System—KITLG—testicular cancer	9.59e-05	0.00126	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—BCL10—testicular cancer	9.58e-05	0.00125	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—BCL10—testicular cancer	9.58e-05	0.00125	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—BCL10—testicular cancer	9.51e-05	0.00124	CbGpPWpGaD
Felodipine—CALM2—B Cell Activation—KIT—testicular cancer	9.39e-05	0.00123	CbGpPWpGaD
Felodipine—CALM1—B Cell Activation—KIT—testicular cancer	9.39e-05	0.00123	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	9.29e-05	0.00122	CbGpPWpGaD
Felodipine—CACNA1C—Developmental Biology—MMP2—testicular cancer	9.28e-05	0.00121	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—BCL10—testicular cancer	9.2e-05	0.0012	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—BCL10—testicular cancer	9.2e-05	0.0012	CbGpPWpGaD
Felodipine—CACNA1C—Metabolism—HPGDS—testicular cancer	9.08e-05	0.00119	CbGpPWpGaD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.98e-05	0.00118	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.98e-05	0.00118	CbGpPWpGaD
Felodipine—PDE1A—Disease—KITLG—testicular cancer	8.85e-05	0.00116	CbGpPWpGaD
Felodipine—PDE1B—Disease—H2AFZ—testicular cancer	8.8e-05	0.00115	CbGpPWpGaD
Felodipine—PDE1B—Immune System—KITLG—testicular cancer	8.77e-05	0.00115	CbGpPWpGaD
Felodipine—PDE1B—Disease—KITLG—testicular cancer	8.1e-05	0.00106	CbGpPWpGaD
Felodipine—CACNB2—Metabolism—STK11—testicular cancer	7.92e-05	0.00104	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.81e-05	0.00102	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—FGFR3—testicular cancer	7.78e-05	0.00102	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—INSL3—testicular cancer	7.64e-05	0.000999	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—FGFR3—testicular cancer	7.53e-05	0.000985	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—FGFR3—testicular cancer	7.53e-05	0.000985	CbGpPWpGaD
Felodipine—CACNA1D—Metabolism—STK11—testicular cancer	7.5e-05	0.000982	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—INSL3—testicular cancer	7.39e-05	0.000967	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—INSL3—testicular cancer	7.39e-05	0.000967	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—KIT—testicular cancer	7.14e-05	0.000935	CbGpPWpGaD
Felodipine—PDE1A—Immune System—FGFR3—testicular cancer	7.13e-05	0.000933	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—KIT—testicular cancer	6.91e-05	0.000904	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—KIT—testicular cancer	6.91e-05	0.000904	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—H2AFZ—testicular cancer	6.74e-05	0.000882	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—STK11—testicular cancer	6.7e-05	0.000877	CbGpPWpGaD
Felodipine—CACNA1C—Metabolism—STK11—testicular cancer	6.59e-05	0.000863	CbGpPWpGaD
Felodipine—PDE1A—Disease—FGFR3—testicular cancer	6.58e-05	0.000861	CbGpPWpGaD
Felodipine—PDE1A—Immune System—KIT—testicular cancer	6.54e-05	0.000856	CbGpPWpGaD
Felodipine—PDE1B—Immune System—FGFR3—testicular cancer	6.52e-05	0.000853	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.36e-05	0.000832	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—KITLG—testicular cancer	6.2e-05	0.000811	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—H2AFZ—testicular cancer	6.16e-05	0.000807	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—STK11—testicular cancer	6.13e-05	0.000802	CbGpPWpGaD
Felodipine—PDE1A—Disease—KIT—testicular cancer	6.04e-05	0.000791	CbGpPWpGaD
Felodipine—PDE1B—Disease—FGFR3—testicular cancer	6.02e-05	0.000788	CbGpPWpGaD
Felodipine—PDE1B—Immune System—KIT—testicular cancer	5.99e-05	0.000783	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—KITLG—testicular cancer	5.97e-05	0.000781	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—KITLG—testicular cancer	5.78e-05	0.000756	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—KITLG—testicular cancer	5.78e-05	0.000756	CbGpPWpGaD
Felodipine—CALM3—Immune System—BCL10—testicular cancer	5.77e-05	0.000755	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—KITLG—testicular cancer	5.73e-05	0.00075	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—KITLG—testicular cancer	5.67e-05	0.000742	CbGpPWpGaD
Felodipine—CALM1—Immune System—BCL10—testicular cancer	5.58e-05	0.00073	CbGpPWpGaD
Felodipine—CALM2—Immune System—BCL10—testicular cancer	5.58e-05	0.00073	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—HPGDS—testicular cancer	5.56e-05	0.000727	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—KITLG—testicular cancer	5.55e-05	0.000726	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—KITLG—testicular cancer	5.55e-05	0.000726	CbGpPWpGaD
Felodipine—PDE1B—Disease—KIT—testicular cancer	5.53e-05	0.000723	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—FGFR3—testicular cancer	4.61e-05	0.000603	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—FGFR3—testicular cancer	4.44e-05	0.000581	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—FGFR3—testicular cancer	4.29e-05	0.000562	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—FGFR3—testicular cancer	4.29e-05	0.000562	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	4.26e-05	0.000558	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—KIT—testicular cancer	4.23e-05	0.000554	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—FGFR3—testicular cancer	4.21e-05	0.000552	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	4.12e-05	0.000539	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	4.12e-05	0.000539	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—KIT—testicular cancer	4.07e-05	0.000533	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—STK11—testicular cancer	4.04e-05	0.000528	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—HPGDS—testicular cancer	4.02e-05	0.000526	CbGpPWpGaD
Felodipine—CALM3—Metabolism—HPGDS—testicular cancer	4e-05	0.000523	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—KIT—testicular cancer	3.94e-05	0.000516	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—KIT—testicular cancer	3.94e-05	0.000516	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—KIT—testicular cancer	3.91e-05	0.000512	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—KIT—testicular cancer	3.87e-05	0.000506	CbGpPWpGaD
Felodipine—CALM1—Metabolism—HPGDS—testicular cancer	3.87e-05	0.000506	CbGpPWpGaD
Felodipine—CALM2—Metabolism—HPGDS—testicular cancer	3.87e-05	0.000506	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—KIT—testicular cancer	3.78e-05	0.000495	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—KIT—testicular cancer	3.78e-05	0.000495	CbGpPWpGaD
Felodipine—CALM3—Disease—H2AFZ—testicular cancer	3.49e-05	0.000457	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—HPGDS—testicular cancer	3.48e-05	0.000455	CbGpPWpGaD
Felodipine—CALM3—Immune System—KITLG—testicular cancer	3.48e-05	0.000455	CbGpPWpGaD
Felodipine—CALM2—Disease—H2AFZ—testicular cancer	3.38e-05	0.000442	CbGpPWpGaD
Felodipine—CALM1—Disease—H2AFZ—testicular cancer	3.38e-05	0.000442	CbGpPWpGaD
Felodipine—CALM2—Immune System—KITLG—testicular cancer	3.36e-05	0.00044	CbGpPWpGaD
Felodipine—CALM1—Immune System—KITLG—testicular cancer	3.36e-05	0.00044	CbGpPWpGaD
Felodipine—CALM3—Disease—KITLG—testicular cancer	3.21e-05	0.00042	CbGpPWpGaD
Felodipine—CALM1—Disease—KITLG—testicular cancer	3.11e-05	0.000406	CbGpPWpGaD
Felodipine—CALM2—Disease—KITLG—testicular cancer	3.11e-05	0.000406	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—HPGDS—testicular cancer	3.03e-05	0.000397	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—STK11—testicular cancer	2.92e-05	0.000382	CbGpPWpGaD
Felodipine—CALM3—Metabolism—STK11—testicular cancer	2.91e-05	0.00038	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—HPGDS—testicular cancer	2.86e-05	0.000374	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—HPGDS—testicular cancer	2.83e-05	0.000371	CbGpPWpGaD
Felodipine—CALM2—Metabolism—STK11—testicular cancer	2.81e-05	0.000368	CbGpPWpGaD
Felodipine—CALM1—Metabolism—STK11—testicular cancer	2.81e-05	0.000368	CbGpPWpGaD
Felodipine—CALM3—Immune System—FGFR3—testicular cancer	2.58e-05	0.000338	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—STK11—testicular cancer	2.53e-05	0.000331	CbGpPWpGaD
Felodipine—CALM1—Immune System—FGFR3—testicular cancer	2.5e-05	0.000327	CbGpPWpGaD
Felodipine—CALM2—Immune System—FGFR3—testicular cancer	2.5e-05	0.000327	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	2.44e-05	0.00032	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—STK11—testicular cancer	2.43e-05	0.000318	CbGpPWpGaD
Felodipine—CALM3—Disease—FGFR3—testicular cancer	2.39e-05	0.000312	CbGpPWpGaD
Felodipine—CALM3—Immune System—KIT—testicular cancer	2.37e-05	0.000311	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	2.36e-05	0.000309	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	2.36e-05	0.000309	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—STK11—testicular cancer	2.35e-05	0.000308	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—STK11—testicular cancer	2.35e-05	0.000308	CbGpPWpGaD
Felodipine—CALM2—Disease—FGFR3—testicular cancer	2.31e-05	0.000302	CbGpPWpGaD
Felodipine—CALM1—Disease—FGFR3—testicular cancer	2.31e-05	0.000302	CbGpPWpGaD
Felodipine—CALM1—Immune System—KIT—testicular cancer	2.3e-05	0.0003	CbGpPWpGaD
Felodipine—CALM2—Immune System—KIT—testicular cancer	2.3e-05	0.0003	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KITLG—testicular cancer	2.25e-05	0.000294	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—STK11—testicular cancer	2.2e-05	0.000288	CbGpPWpGaD
Felodipine—CALM3—Disease—KIT—testicular cancer	2.19e-05	0.000287	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KITLG—testicular cancer	2.18e-05	0.000285	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KITLG—testicular cancer	2.18e-05	0.000285	CbGpPWpGaD
Felodipine—CALM1—Disease—KIT—testicular cancer	2.12e-05	0.000277	CbGpPWpGaD
Felodipine—CALM2—Disease—KIT—testicular cancer	2.12e-05	0.000277	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—STK11—testicular cancer	2.08e-05	0.000272	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—STK11—testicular cancer	2.06e-05	0.000269	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.87e-05	0.000244	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—FGFR3—testicular cancer	1.67e-05	0.000219	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—FGFR3—testicular cancer	1.62e-05	0.000212	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—FGFR3—testicular cancer	1.62e-05	0.000212	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KIT—testicular cancer	1.53e-05	0.000201	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KIT—testicular cancer	1.48e-05	0.000194	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KIT—testicular cancer	1.48e-05	0.000194	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—STK11—testicular cancer	1.36e-05	0.000178	CbGpPWpGaD
